Intercure Financial Statements From 2010 to 2024

INCR Stock  ILS 484.80  8.20  1.66%   
Intercure financial statements provide useful quarterly and yearly information to potential Intercure investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Intercure financial statements helps investors assess Intercure's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Intercure's valuation are summarized below:
Intercure does not presently have any fundamental trends for analysis.
Check Intercure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intercure's main balance sheet or income statement drivers, such as , as well as many indicators such as . Intercure financial statements analysis is a perfect complement when working with Intercure Valuation or Volatility modules.
  
This module can also supplement various Intercure Technical models . Check out the analysis of Intercure Correlation against competitors.

Intercure Company Profit Margin Analysis

Intercure's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Intercure Profit Margin

    
  0.09 %  
Most of Intercure's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intercure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Intercure has a Profit Margin of 0.0915%. This is 100.82% lower than that of the Health Care Equipment & Supplies sector and 101.68% lower than that of the Health Care industry. The profit margin for all Israel stocks is 107.2% lower than that of the firm.

Intercure Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Intercure's current stock value. Our valuation model uses many indicators to compare Intercure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intercure competition to find correlations between indicators driving Intercure's intrinsic value. More Info.
Intercure is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about  0.73  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Intercure is roughly  1.37 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Intercure by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Intercure's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Intercure Financial Statements

Intercure stakeholders use historical fundamental indicators, such as Intercure's revenue or net income, to determine how well the company is positioned to perform in the future. Although Intercure investors may analyze each financial statement separately, they are all interrelated. For example, changes in Intercure's assets and liabilities are reflected in the revenues and expenses on Intercure's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Intercure. Please read more on our technical analysis and fundamental analysis pages.
InterCure Ltd. invests in the biomedical, life sciences, and biotechnology sectors in Israel and internationally. InterCure Ltd. was founded in 1994 and is based in Hadera, Israel. INTERCURE LTD is traded on Tel Aviv Stock Exchange in Israel.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Intercure Stock

Intercure financial ratios help investors to determine whether Intercure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intercure with respect to the benefits of owning Intercure security.